EGFR and prostate carcinoma: Additionally, it was revealed that in breast [305] and prostate cancers [306] ACKR3 may form heterodimers of another type, with epidermal growth factor receptor (EGFR), what contributes to promoting tumor cell proliferation in these malignancies.